Patent ID: 6051605
Filing Date: 2000-04-18
Classification: A61K

Abstract:
A method of treating psychosis or schizophrenia, the method comprising administering to a patient suffering therefrom a therapeutically effective amount of a compound having the Formula I ##STR4## wherein R.sup.1 and R.sup.2 are independently hydrogen, hydroxy, C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkoxy, halogen, nitro, phenyl, cyano, carboxy, carboxyamido, carboxyalkyloxy, C.sub.1 -C.sub.6 alkylamino, or C.sub.1 -C.sub.6 dialkylamino;R.sup.3 is hydrogen, hydroxy, or C.sub.1 -C.sub.6 alkyl;X is CH.sub.2, or SO.sub.2 ;Y is O, CH.sub.2, S, SO, or SO.sub.2 ;m and n are independently 1-3;provided that X and Y are not both CH.sub.2, further provided that one of R.sup.1 and R.sup.2 is not hydrogen, or the pharmaceutically acceptable salts thereof.